334 related articles for article (PubMed ID: 26361281)
1. Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
Kushnirsky M; Nguyen V; Katz JS; Steinklein J; Rosen L; Warshall C; Schulder M; Knisely JP
J Neurosurg; 2016 Feb; 124(2):489-95. PubMed ID: 26361281
[TBL] [Abstract][Full Text] [Related]
2. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
5. High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
Pinker K; Noebauer-Huhmann IM; Stavrou I; Hoeftberger R; Szomolanyi P; Weber M; Stadlbauer A; Grabner G; Knosp E; Trattnig S
Neuroradiology; 2008 Jan; 50(1):9-16. PubMed ID: 17876570
[TBL] [Abstract][Full Text] [Related]
6. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
8. Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield.
Cohen-Inbar O; Xu Z; Dodson B; Rizvi T; Durst CR; Mukherjee S; Sheehan JP
J Neurooncol; 2016 Dec; 130(3):485-494. PubMed ID: 27568036
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience.
Ali MA; Carroll KT; Rennert RC; Hamelin T; Chang L; Lemkuil BP; Sharma M; Barnholtz-Sloan JS; Myers C; Barnett GH; Smith K; Mohammadi AM; Sloan AE; Chen CC
Neurosurg Focus; 2016 Oct; 41(4):E11. PubMed ID: 27690654
[TBL] [Abstract][Full Text] [Related]
10. Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery.
Jarvis LA; Simmons NE; Bellerive M; Erkmen K; Eskey CJ; Gladstone DJ; Hug EB; Roberts DW; Hartford AC
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):943-8. PubMed ID: 22494581
[TBL] [Abstract][Full Text] [Related]
11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
[TBL] [Abstract][Full Text] [Related]
13. Brain metastasis growth on preradiosurgical magnetic resonance imaging.
Garcia MA; Anwar M; Yu Y; Duriseti S; Merritt B; Nakamura J; Hess C; Theodosopoulos PV; McDermott M; Sneed PK; Braunstein SE
Pract Radiat Oncol; 2018; 8(6):e369-e376. PubMed ID: 30174247
[TBL] [Abstract][Full Text] [Related]
14. Use of 3.0-T MRI for stereotactic radiosurgery planning for treatment of brain metastases: a single-institution retrospective review.
Saconn PA; Shaw EG; Chan MD; Squire SE; Johnson AJ; McMullen KP; Tatter SB; Ellis TL; Lovato J; Bourland JD; Ekstrand KE; DeGuzman AF; Munley MT
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1142-6. PubMed ID: 20832185
[TBL] [Abstract][Full Text] [Related]
15. Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.
Anzalone N; Essig M; Lee SK; Dörfler A; Ganslandt O; Combs SE; Picozzi P
Neurosurgery; 2013 May; 72(5):691-701. PubMed ID: 23381488
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided Detection of Brain Metastases in T1-weighted MRI for Stereotactic Radiosurgery Using Deep Learning Single-Shot Detectors.
Zhou Z; Sanders JW; Johnson JM; Gule-Monroe MK; Chen MM; Briere TM; Wang Y; Son JB; Pagel MD; Li J; Ma J
Radiology; 2020 May; 295(2):407-415. PubMed ID: 32181729
[TBL] [Abstract][Full Text] [Related]
18. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
Errante Y; Cirimele V; Mallio CA; Di Lazzaro V; Zobel BB; Quattrocchi CC
Invest Radiol; 2014 Oct; 49(10):685-90. PubMed ID: 24872007
[TBL] [Abstract][Full Text] [Related]
19. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
20. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
